• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普瑞特罗和吡布特罗对β-1肾上腺素能受体的相对效能:通过受体数量改变测定激动剂亲和力

Relative efficacy of prenalterol and pirbuterol for beta-1 adrenoceptors: measurement of agonist affinity by alteration of receptor number.

作者信息

Kenakin T P, Beek D

出版信息

J Pharmacol Exp Ther. 1984 May;229(2):340-5.

PMID:6143816
Abstract

Both prenalterol and pirbuterol are partial agonists (when compared to isoproterenol) in rat left atria. Schild analysis with the beta-1 adrenoceptor selective antagonist atenolol indicated that all three agonists stimulate beta-1 adrenoceptors in this preparation. Atria from rats implanted with mini-osmotic pumps which delivered isoproterenol (400 micrograms kg-1 hr-1) s.c. for 4 days were 9 times less sensitive than control, to isoproterenol, and produced no responses to either prenalterol or pirbuterol. Schild analysis with atenolol on these desensitized atria indicated a homogeneous population of beta-1 adrenoceptors. In the desensitized atria, both prenalterol and pirbuterol functioned as competitive antagonists of responses to isoproterenol and Schild analysis yielded estimates of the equilibrium dissociation constants (Kp) of prenalterol (0.09 micron) and pirbuterol (2 micron) in these tissues. The estimates of Kp were utilized to calculate the relative efficacy of pirbuterol and prenalterol; pirbuterol was shown to have 2.3 times the efficacy of prenalterol on beta-1 adrenoceptors. The implications of this method as a means of calculating the Kp for partial agonists are discussed. These data also serve as a caveat to the use of pirbuterol in the determination of functional cardiac beta adrenoceptor subtypes in experimental animals and in man.

摘要

在大鼠左心房中,普瑞特罗和吡布特罗均为部分激动剂(与异丙肾上腺素相比)。使用β1肾上腺素能受体选择性拮抗剂阿替洛尔进行的希尔德分析表明,这三种激动剂在此制剂中均刺激β1肾上腺素能受体。给大鼠皮下植入微型渗透泵,持续4天给予异丙肾上腺素(400微克/千克·小时),其心房对异丙肾上腺素的敏感性比对照组低9倍,对普瑞特罗或吡布特罗均无反应。用阿替洛尔对这些脱敏心房进行希尔德分析表明,存在均匀的β1肾上腺素能受体群体。在脱敏心房中,普瑞特罗和吡布特罗均作为异丙肾上腺素反应的竞争性拮抗剂起作用,希尔德分析得出了这些组织中普瑞特罗(0.09微摩尔)和吡布特罗(2微摩尔)的平衡解离常数(Kp)估计值。利用Kp估计值计算了吡布特罗和普瑞特罗的相对效能;结果表明,吡布特罗对β1肾上腺素能受体的效能是普瑞特罗的2.3倍。讨论了该方法作为计算部分激动剂Kp的一种手段的意义。这些数据也警示了在实验动物和人类中使用吡布特罗来确定功能性心脏β肾上腺素能受体亚型的情况。

相似文献

1
Relative efficacy of prenalterol and pirbuterol for beta-1 adrenoceptors: measurement of agonist affinity by alteration of receptor number.普瑞特罗和吡布特罗对β-1肾上腺素能受体的相对效能:通过受体数量改变测定激动剂亲和力
J Pharmacol Exp Ther. 1984 May;229(2):340-5.
2
Theoretical and practical problems with the assessment of intrinsic efficacy of agonists: efficacy of reputed beta-1 selective adrenoceptor agonists for beta-2 adrenoceptors.激动剂内在效能评估的理论与实践问题:公认的β-1选择性肾上腺素能受体激动剂对β-2肾上腺素能受体的效能
J Pharmacol Exp Ther. 1982 Nov;223(2):416-23.
3
Effects of in vivo beta-adrenoceptor down-regulation on cardiac responses to prenalterol and pirbuterol.体内β-肾上腺素能受体下调对心脏对普瑞特罗和吡布特罗反应的影响。
J Cardiovasc Pharmacol. 1983 Jan-Feb;5(1):90-7. doi: 10.1097/00005344-198301000-00014.
4
Intrinsic sympathomimetic activity of the partial agonist prenalterol in relation to beta adrenoceptor interaction in various tissues, in vitro.部分激动剂普瑞特罗的内在拟交感活性与体外各种组织中β肾上腺素能受体相互作用的关系。
J Pharmacol Exp Ther. 1983 Mar;224(3):654-61.
5
Responses to the beta 2-selective agonist procaterol of vascular and atrial preparations with different functional beta-adrenoceptor populations.对具有不同功能性β-肾上腺素能受体群体的血管和心房制剂对β2选择性激动剂丙卡特罗的反应。
Br J Pharmacol. 1985 Jan;84(1):227-35.
6
Prenalterol is an agonist at beta 2- as well as at beta 1-adrenoceptors.普瑞纳洛尔是β2 - 肾上腺素能受体以及β1 - 肾上腺素能受体的激动剂。
Eur J Pharmacol. 1982 Jul 30;81(4):659-63. doi: 10.1016/0014-2999(82)90356-9.
7
The measurement of the relative efficacy of agonists by selective potentiation of tissue responses: studies with isoprenaline and prenalterol in cardiac tissue.通过组织反应的选择性增强来测量激动剂的相对效力:在心脏组织中使用异丙肾上腺素和普瑞特罗的研究
J Auton Pharmacol. 1984 Sep;4(3):153-9. doi: 10.1111/j.1474-8673.1984.tb00092.x.
8
beta 1-and beta 2-adrenoceptor stimulatory effects of prenalterol.普瑞特罗对β1和β2肾上腺素能受体的刺激作用。
Naunyn Schmiedebergs Arch Pharmacol. 1982 Dec;321(4):302-8. doi: 10.1007/BF00498518.
9
Effects of selective and nonselective beta-agonists on plasma potassium and norepinephrine.选择性和非选择性β-激动剂对血浆钾和去甲肾上腺素的影响。
J Cardiovasc Pharmacol. 1984 Jan-Feb;6(1):107-14.
10
Studies on mechanisms for beta-adrenoceptor mediated inhibition of colon motility.β-肾上腺素能受体介导的结肠运动抑制机制的研究。
Acta Physiol Scand Suppl. 1985;546:1-39.

引用本文的文献

1
Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.哮喘和 COPD:聚焦β-激动剂——过去、现在和未来。
Handb Exp Pharmacol. 2024;285:369-451. doi: 10.1007/164_2023_679.
2
Pharmacology and direct visualisation of BODIPY-TMR-CGP: a long-acting fluorescent beta2-adrenoceptor agonist.BODIPY-TMR-CGP的药理学及直接可视化:一种长效荧光β2肾上腺素能受体激动剂
Br J Pharmacol. 2003 May;139(2):232-42. doi: 10.1038/sj.bjp.0705287.
3
Pharmacological characterization of CGP 12177 at the human beta(2)-adrenoceptor.CGP 12177对人β₂肾上腺素能受体的药理学特性研究
Br J Pharmacol. 2002 Oct;137(3):400-8. doi: 10.1038/sj.bjp.0704855.
4
A new ligand for the urotensin II receptor.一种新型的尿紧张素II受体配体。
Br J Pharmacol. 2002 Oct;137(3):311-4. doi: 10.1038/sj.bjp.0704895.
5
Inhibition of some aspects of acute inflammation of guinea-pig lung by intraperitoneal dexamethasone and mifepristone: demonstration of agonist activity of mifepristone in the guinea-pig.腹腔注射地塞米松和米非司酮对豚鼠肺急性炎症某些方面的抑制作用:米非司酮在豚鼠体内激动剂活性的证明
Inflamm Res. 1995 Mar;44(3):131-8. doi: 10.1007/BF01782024.
6
Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity.具有部分激动活性的β-肾上腺素受体拮抗剂(非选择性以及β1选择性)可降低人淋巴细胞中的β2-肾上腺素受体密度。部分激动活性中β2激动成分的证据。
Naunyn Schmiedebergs Arch Pharmacol. 1986 Jun;333(2):130-8. doi: 10.1007/BF00506515.
7
Beta 1- and beta 2-adrenoceptor binding and functional response in right and left atria of rat heart.大鼠心脏左右心房中β1和β2肾上腺素能受体结合及功能反应
Naunyn Schmiedebergs Arch Pharmacol. 1985 Sep;330(3):193-202. doi: 10.1007/BF00572434.
8
Pirbuterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible bronchospastic disease.
Drugs. 1985 Jul;30(1):6-21. doi: 10.2165/00003495-198530010-00002.
9
Desensitization and functional antagonism by beta-adrenoceptor and muscarinic receptor agonists, respectively: a comparison with receptor alkylation for calculation of apparent agonist affinity.分别通过β-肾上腺素能受体激动剂和毒蕈碱受体激动剂进行脱敏和功能拮抗:与受体烷基化用于计算表观激动剂亲和力的比较
Br J Pharmacol. 1991 Aug;103(4):1951-7. doi: 10.1111/j.1476-5381.1991.tb12358.x.